<p>IL: intratumoral lymphocytes; PL: peritunoral lymphocytes; TC: tumor cells; UK: United Kingdom; estrogen receptor; NP: not provided; UA: univariate analysis; MA: multivariate analysis; O: observational study; E: experimental study; OS: overallsurvival; DFS: disease-free survival; CP: clinicopathological parameters.</p><p>Main characteristics of the included studies.</p
<p>ER, estrogen receptor; PR, progesterone receptor</p><p><sup>1</sup>Not all patients had informati...
<p><b>Abbreviations:</b> OS, over survival; GC, gastric cancer; IHC, immunohistochemistry; RT-PCR, r...
<p><i>NR</i> not reported, <i>POSI</i> positive, <i>T</i> tumor cells, <i>S</i> stromal cells, <i>CS...
<p><sup>a</sup>Tumor stage and percentage of advanced stage(%); NR, Not Reported; CTCs, circulating ...
<p>LVI: lymphovascular invasion; HR: hormone receptor; AST: adjuvant systemic therapy; ER: estrogen ...
<p><b>Abbreviations:</b> No. of subjects, Number of subjects; MDS, Myelodysplastic Syndrome; AML, Ac...
<p>Abbreviation: PMID, PubMed Id; G, gender; D, differentiation; S, UICC stage; Du, Dukès classifica...
<p>*All samples.</p><p>**Cancer samples only. ER: estrogen receptor.</p><p>PR: progesterone receptor...
<p>Tumorigenicity and tumor classification is based on published data <a href="http://www.plosone.or...
<p>Note: Pem for pemetrexed; Doc for doctaxel; Erl for erlotinib; PFS means progression-free surviva...
<p>APAAP = alkaline phosphatase-anti-alkaline phosphatase complex method, HSCT = Hematopoietic stem ...
<p>The Descriptive Characteristics of the Multiethnic Case-Control Studies of Breast and Prostate Ca...
1<p>Studies that used criteria that were similar but not identical to the EORTC/MSG criteria.</p><p>...
<p>Note: HCC = hepatocellular carcinoma, HB = hepatoblastoma, CCA = cholangiocarcinoma, TT = tumor ...
<p>N, sample size; AE, adverse event; KFS, Karnofsky performance score; RECIST, Response Evaluation ...
<p>ER, estrogen receptor; PR, progesterone receptor</p><p><sup>1</sup>Not all patients had informati...
<p><b>Abbreviations:</b> OS, over survival; GC, gastric cancer; IHC, immunohistochemistry; RT-PCR, r...
<p><i>NR</i> not reported, <i>POSI</i> positive, <i>T</i> tumor cells, <i>S</i> stromal cells, <i>CS...
<p><sup>a</sup>Tumor stage and percentage of advanced stage(%); NR, Not Reported; CTCs, circulating ...
<p>LVI: lymphovascular invasion; HR: hormone receptor; AST: adjuvant systemic therapy; ER: estrogen ...
<p><b>Abbreviations:</b> No. of subjects, Number of subjects; MDS, Myelodysplastic Syndrome; AML, Ac...
<p>Abbreviation: PMID, PubMed Id; G, gender; D, differentiation; S, UICC stage; Du, Dukès classifica...
<p>*All samples.</p><p>**Cancer samples only. ER: estrogen receptor.</p><p>PR: progesterone receptor...
<p>Tumorigenicity and tumor classification is based on published data <a href="http://www.plosone.or...
<p>Note: Pem for pemetrexed; Doc for doctaxel; Erl for erlotinib; PFS means progression-free surviva...
<p>APAAP = alkaline phosphatase-anti-alkaline phosphatase complex method, HSCT = Hematopoietic stem ...
<p>The Descriptive Characteristics of the Multiethnic Case-Control Studies of Breast and Prostate Ca...
1<p>Studies that used criteria that were similar but not identical to the EORTC/MSG criteria.</p><p>...
<p>Note: HCC = hepatocellular carcinoma, HB = hepatoblastoma, CCA = cholangiocarcinoma, TT = tumor ...
<p>N, sample size; AE, adverse event; KFS, Karnofsky performance score; RECIST, Response Evaluation ...
<p>ER, estrogen receptor; PR, progesterone receptor</p><p><sup>1</sup>Not all patients had informati...
<p><b>Abbreviations:</b> OS, over survival; GC, gastric cancer; IHC, immunohistochemistry; RT-PCR, r...
<p><i>NR</i> not reported, <i>POSI</i> positive, <i>T</i> tumor cells, <i>S</i> stromal cells, <i>CS...